Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis

NCT02036229 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rabin Medical Center